Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$453K Sell
23,800
-32,200
-58% -$622K ﹤0.01% 2746
2025
Q4
$917K Buy
56,000
+20,100
+56% +$354K ﹤0.01% 2504
2025
Q3
$675K Buy
35,900
+13,100
+57% +$235K ﹤0.01% 2378
2025
Q2
$461K Sell
22,800
-58,500
-72% -$1.01M ﹤0.01% 2711
2025
Q1
$1.12M Buy
81,300
+22,700
+39% +$313K 0.01% 1874
2024
Q4
$694K Buy
58,600
+48,400
+475% +$762K ﹤0.01% 2704
2024
Q3
$183K Sell
10,200
-36,600
-78% -$667K ﹤0.01% 4063
2024
Q2
$823K Sell
46,800
-26,000
-36% -$537K ﹤0.01% 3040
2024
Q1
$1.87M Sell
72,800
-3,300
-4% -$82.8K ﹤0.01% 2045
2023
Q4
$1.98M Buy
76,100
+44,300
+139% +$1.01M ﹤0.01% 1784
2023
Q3
$733K Sell
31,800
-50,900
-62% -$1.28M ﹤0.01% 2501
2023
Q2
$1.94M Buy
82,700
+28,300
+52% +$480K 0.01% 1358
2023
Q1
$646K Buy
+54,400
New +$775K 0.01% 1495

Other funds holding XP

Walleye Capital's XP Position: Q1 2026 in Review

Walleye Capital reduced its XP (XP) stake by 100% in Q1 2026, selling an estimated $317K and leaving 10 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #4290.

Walleye Capital first reported a position in XP in Q4 2020 and has held it in 12 quarters since. The position peaked at $8.4M in Q1 2025. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • Walleye Capital held 10 shares of XP worth $190 as of Q1 2026.
  • Walleye Capital sold 16,422 XP shares in Q1 2026, an estimated $317K.
  • XP made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4290 holding.
  • Walleye Capital first reported a position in XP in Q4 2020 and has held it in 12 quarters since.
  • Walleye Capital's XP position peaked at $8.4M in Q1 2025.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.